patient
man
histori
common
variabl
immunodefici
cvid
associ
heterozyg
mutat
taci
granulomat
lymphocyt
interstiti
lung
diseas
glild
massiv
splenomegali
immun
thrombocytopenia
autoimmun
hemolyt
anemia
present
histori
fever
temperatur
c
malais
sinu
congest
intermitt
headach
loos
stool
cough
dyspnea
vomit
abdomin
pain
joint
pain
rash
nonadher
weekli
home
dose
subcutan
immunoglobulin
therapi
hypogammaglobulinemia
report
take
total
dose
previou
month
recent
dose
day
present
treat
immunoglobulin
replac
sinc
year
age
cvid
diagnos
base
clinic
histori
recurr
sinu
ear
infect
low
pretreat
immunoglobulin
level
igg
mgdl
iga
mgdl
igm
mgdl
poor
specif
antibodi
respons
vaccin
year
age
treat
weekli
dose
rituximab
improv
chronic
thrombocytopenia
reduct
splenomegali
radiograph
resolut
lung
diseas
month
rituximab
treatment
patient
redevelop
thrombocytopenia
splenomegali
lung
diseas
time
patient
famili
given
option
repeat
rituximab
therapi
consid
bone
marrow
transplant
chose
pursu
therapi
rel
asymptomat
time
sinc
intermitt
sinu
skin
infect
treat
outpati
set
last
report
infect
abscess
thigh
occur
month
earlier
abscess
treat
success
emerg
depart
trimethoprimsulfamethoxazol
antibiot
therapi
addit
histori
reveal
bilater
chest
pain
preced
week
attribut
patient
muscl
strain
vital
sign
includ
temperatur
c
slight
tachycardia
heart
rate
slight
tachypnea
respiratori
rate
blood
pressur
mm
hg
normal
oxygen
satur
examin
find
notabl
nontox
gener
appear
ulcer
present
base
tongu
massiv
splenomegali
signific
nasal
congest
lung
clear
auscult
respiratori
distress
result
initi
blood
cell
count
studi
given
tabl
result
serum
electrolyt
measur
liver
function
test
urinalysi
unremark
result
respiratori
viru
polymeras
chain
reaction
pcr
panel
perform
nasopharyng
swab
specimen
posit
rhinoviru
neg
influenza
influenza
b
parainfluenza
respiratori
syncyti
viru
human
metapneumoviru
coronaviru
result
rapid
streptococc
antigen
detect
test
perform
throat
swab
specimen
neg
chest
radiographi
reveal
possibl
right
lower
lobe
pneumonia
treatment
ceftriaxon
azithromycin
start
along
ibuprofen
headach
dose
intraven
immunoglobulin
given
serum
igg
level
intraven
immunoglobulin
therapi
mgdl
though
acut
distress
current
afebril
decis
made
admit
patient
even
close
monitor
intraven
antibiot
treatment
pneumonia
patient
develop
fever
temperatur
c
noon
follow
day
continu
fever
day
peak
temperatur
c
period
workup
expand
context
continu
fever
lack
respiratori
symptom
cough
wheez
short
breath
histori
reveal
clean
window
gutter
reprint
patient
man
histori
common
variabl
immunodefici
cvid
associ
heterozyg
mutat
taci
granulomat
lymphocyt
interstiti
lung
diseas
glild
massiv
splenomegali
immun
thrombocytopenia
autoimmun
hemolyt
anemia
present
histori
fever
temperatur
c
malais
sinu
congest
intermitt
headach
loos
stool
cough
dyspnea
vomit
abdomin
pain
joint
pain
rash
nonadher
weekli
home
dose
subcutan
immunoglobulin
therapi
hypogammaglobulinemia
report
take
total
dose
previou
month
recent
dose
day
present
treat
immunoglobulin
replac
sinc
year
age
cvid
diagnos
base
clinic
histori
recurr
sinu
ear
infect
low
pretreat
immunoglobulin
level
igg
mgdl
iga
mgdl
igm
mgdl
poor
specif
antibodi
respons
vaccin
year
age
treat
weekli
dose
rituximab
improv
chronic
thrombocytopenia
reduct
splenomegali
radiograph
resolut
lung
diseas
month
rituximab
treatment
patient
redevelop
thrombocytopenia
splenomegali
lung
diseas
time
patient
famili
given
option
repeat
rituximab
therapi
consid
bone
marrow
transplant
chose
pursu
therapi
rel
asymptomat
time
sinc
intermitt
sinu
skin
infect
treat
outpati
set
last
report
infect
abscess
thigh
occur
month
earlier
abscess
treat
success
emerg
depart
trimethoprimsulfamethoxazol
antibiot
therapi
addit
histori
reveal
bilater
chest
pain
preced
week
attribut
patient
muscl
strain
vital
sign
includ
temperatur
c
slight
tachycardia
heart
rate
slight
tachypnea
respiratori
rate
blood
pressur
mm
hg
normal
oxygen
satur
examin
find
notabl
nontox
gener
appear
ulcer
present
base
tongu
massiv
splenomegali
signific
nasal
congest
lung
clear
auscult
respiratori
distress
result
initi
blood
cell
count
studi
given
tabl
result
serum
electrolyt
measur
liver
function
test
urinalysi
unremark
result
respiratori
viru
polymeras
chain
reaction
pcr
panel
perform
nasopharyng
swab
specimen
posit
rhinoviru
neg
influenza
influenza
b
parainfluenza
respiratori
syncyti
viru
human
metapneumoviru
coronaviru
result
rapid
streptococc
antigen
detect
test
perform
throat
swab
specimen
neg
chest
radiographi
reveal
possibl
right
lower
lobe
pneumonia
treatment
ceftriaxon
azithromycin
start
along
ibuprofen
headach
dose
intraven
immunoglobulin
given
serum
igg
level
intraven
immunoglobulin
therapi
mgdl
though
acut
distress
current
afebril
decis
made
admit
patient
even
close
monitor
intraven
antibiot
treatment
pneumonia
patient
develop
fever
temperatur
c
noon
follow
day
continu
fever
day
peak
temperatur
c
period
workup
expand
context
continu
fever
lack
respiratori
symptom
cough
wheez
short
breath
histori
reveal
clean
window
gutter
employ
past
month
around
pet
bird
girlfriend
hous
father
die
metastat
colon
cancer
matern
grandmoth
die
breast
cancer
spectrum
antimicrobi
coverag
broaden
chang
antibiot
cefepim
levofloxacin
blood
test
result
neg
human
immunodefici
viru
cytomegaloviru
epsteinbarr
viru
human
herpesviru
human
herpesviru
parvoviru
pcr
swab
specimen
tongu
ulcer
neg
herp
simplex
viru
pcr
urin
histoplasmosi
antigen
test
comput
tomographi
ct
scan
head
sinus
chest
abdomen
pelvi
perform
new
lesion
lower
pole
right
kidney
note
describ
illdefin
expansil
lesion
hypodens
rel
normal
enhanc
left
kidney
without
cyst
calcif
cavit
fig
ct
find
includ
evid
fluid
maxillari
sinus
suggest
acut
sinus
intracrani
abnorm
patchi
confluent
groundglass
opac
throughout
lung
multipl
peripher
area
consolid
increas
compar
ct
perform
year
earlier
fig
multipl
enlarg
mediastin
abdominopelv
lymph
node
slightli
increas
size
prior
ct
massiv
splenomegali
note
previous
fungal
ball
mycetoma
sign
identifi
ct
context
ongo
fever
right
kidney
mass
thought
infect
vs
tumor
cefepim
chang
doxycyclin
addit
staphylococcu
coverag
given
histori
skin
abscess
given
concern
possibl
lymphoma
lactat
dehydrogenas
uric
acid
level
measur
normal
urin
histoplasmosi
antigen
test
result
posit
prompt
initi
cours
itraconazol
led
defervesc
second
day
therapi
fig
bronchoalveolar
lavag
specimen
obtain
test
posit
cytomegaloviru
therefor
treatment
valganciclovir
initi
percutan
biopsi
right
kidney
mass
perform
biopsi
reveal
extens
infiltr
destruct
renal
tissu
lymphoprolif
lesion
compos
mostli
small
lymphoid
cell
occasion
larg
transform
cell
fig
immunohistochemistri
reveal
cell
lesion
low
prolif
activ
flow
cytometri
detect
abnorm
bcell
popul
surfac
k
light
chain
restrict
abnorm
b
cell
posit
hladr
neg
although
possibl
express
marker
small
subset
neg
morpholog
test
immunophenotyp
result
consist
extranod
margin
zone
lymphoma
mucosaassoci
lymphoid
tissu
malt
attempt
obtain
gband
karyotyp
unsuccess
failur
cell
grow
cultur
molecular
clonal
test
consid
perform
renal
malt
lymphoma
surgic
resect
immunotherapi
watch
wait
present
initi
option
watch
wait
select
patient
surveil
program
involv
ct
ultrasonographi
initi
six
month
diagnosi
slight
decreas
size
renal
lesion
chang
splenomegali
retroperiton
lymphadenopathi
year
diagnosi
renal
mass
longer
seen
ultrasonographi
cvid
primari
immunodefici
diseas
involv
reduc
serum
concentr
igg
reduc
iga
andor
igm
impair
product
specif
antibodi
respons
antigen
typic
document
poor
respons
vaccin
decreas
quantiti
andor
function
b
cell
typic
caus
humor
deficit
although
abnorm
tcell
regul
b
cell
also
caus
recurr
sinopulmonari
tract
infect
main
complic
patient
cvid
approxim
half
patient
cvid
least
one
episod
pneumonia
patient
cvid
multipl
episod
pneumonia
common
infect
includ
bronchiti
sinus
otiti
media
immunoglobulin
replac
standard
care
reduc
frequenc
infect
patient
cvid
increas
risk
autoimmun
diseas
granulomat
diseas
malign
tumor
lymphoma
patient
cvid
develop
glild
restrict
lung
diseas
associ
greater
morbid
earlier
mortal
lymphadenopathi
splenomegali
seen
onequart
patient
cvid
splenomegali
associ
granulomat
diseas
autoimmun
diseas
histoplasmosi
caus
organ
histoplasma
capsulatum
common
endem
mycosi
unit
state
inhabit
major
river
valley
central
southern
unit
state
fungal
spore
lead
infect
airborn
higher
concentr
soil
contain
bird
bat
drop
infect
gener
asymptomat
dissemin
diseas
occur
particularli
immunocompromis
patient
common
clinic
manifest
includ
fever
respiratori
symptom
hepatomegali
splenomegali
lymphadenopathi
gastrointestin
symptom
weight
loss
oropharyng
ulcer
common
occur
twothird
patient
dissemin
histoplasmosi
diagnost
laboratori
test
histoplasmosi
includ
cultur
fungal
stain
antigen
detect
serolog
test
although
rapid
diagnosi
attain
antigen
test
urin
enzym
immunoassay
histoplasma
antigen
urin
detect
approxim
nonimmunocompromis
patient
immunocompromis
patient
treatment
dissemin
histoplasmosi
depend
sever
ill
includ
amphotericin
b
formul
moder
sever
diseas
itraconazol
mild
moder
diseas
patient
fever
splenomegali
tongu
ulcer
physic
find
consist
dissemin
histoplasmosi
along
histori
near
pet
bird
clean
window
gutter
would
increas
risk
exposur
histoplasma
spore
splenomegali
howev
new
discoveri
actual
previous
known
clinic
find
associ
cvid
glild
patient
may
suscept
histoplasmosi
dysregul
cellmedi
immun
associ
cvid
evidenc
low
respons
antigen
mitogen
stimul
assay
perform
month
present
tabl
increas
lung
groundglass
opac
mediastin
abdominopelv
lymphadenopathi
possibl
lymphocyt
respons
infect
although
lung
lymph
node
biopsi
specimen
prove
respond
well
itraconazol
therapi
resolut
fever
within
hour
treatment
initi
dissemin
histoplasmosi
immunodefici
patient
primarili
report
patient
aid
less
patient
primari
immunodefici
cvid
reactiv
latent
infect
report
patient
chronic
immunosuppress
chemotherapi
longterm
steroid
use
aid
although
patient
last
receiv
immunosuppress
therapi
rituximab
year
ago
medic
record
review
patient
yield
document
prior
histoplasmosi
infect
found
case
report
histoplasma
infect
patient
cvid
man
initi
present
dizzi
tinnitu
confus
diagnos
histoplasma
mening
woman
present
lower
gastrointestin
tract
bleed
diagnos
dissemin
histoplasmosi
find
cecal
ulcer
man
present
chronic
diarrhea
weight
loss
along
whitish
necrot
lesion
tongu
ultim
diagnos
dissemin
histoplasmosi
patient
differ
case
report
neurolog
gastrointestin
symptom
tongu
lesion
similar
case
report
male
patient
patient
malt
lymphoma
kidney
like
relat
histori
cvid
autoimmun
malt
lymphoma
rare
cancer
especi
rare
cvid
believ
form
lymphoid
tissu
secondari
chronic
inflammatori
autoimmun
stimul
review
malt
lymphoma
patient
cvid
mention
publish
case
time
primari
site
involv
lung
case
parotid
gland
case
paranas
sinus
case
orbit
caviti
case
patient
uniqu
malt
lymphoma
locat
kidney
rare
site
involv
previous
report
patient
cvid
malt
lymphoma
overal
indol
malign
tumor
good
prognosi
surviv
rate
greater
surviv
rate
although
recurr
occur
median
year
treatment
prognosi
malt
lymphoma
specif
set
cvid
systemat
studi
report
patient
malt
lymphoma
spontan
regress
without
intervent
longer
detect
ultrasonographi
within
year
initi
diagnosi
interest
find
anecdot
report
spontan
remiss
adult
patient
ocular
pulmonari
malt
lymphoma
tempor
associ
discoveri
resolut
lesion
histoplasmosi
infect
patient
rais
question
whether
infect
could
influenc
format
malt
lymphoma
fungal
modul
immun
system
evid
histoplasma
subvert
innat
immun
system
hide
bglucan
phagocyt
receptor
recognit
use
layer
alink
glucan
combin
glucanas
reduc
level
expos
bglucan
abl
find
evid
tactic
influenc
adapt
immun
system
way
would
increas
risk
malign
tumor
awar
previous
report
associ
support
suggest
direct
associ
histoplasmosi
malt
lymphoma
therapi
malt
lymphoma
includ
watch
wait
local
radiotherapi
vs
surgic
resect
antibiot
case
gastric
malt
lymphoma
associ
helicobact
pylori
system
treatment
chemotherapi
immunomodulatori
agent
note
treatment
modal
cvidglild
malt
lymphoma
similar
rituximab
highlight
potenti
dual
benefit
treatment
patient
